These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

576 related items for PubMed ID: 15104191

  • 1. Specific ultrarush desensitization in Hymenoptera venom-allergic patients.
    Schiavino D, Nucera E, Pollastrini E, De Pasquale T, Buonomo A, Bartolozzi F, Lombardo C, Roncallo C, Patriarca G.
    Ann Allergy Asthma Immunol; 2004 Apr; 92(4):409-13. PubMed ID: 15104191
    [Abstract] [Full Text] [Related]

  • 2. Analysis of safety, risk factors and pretreatment methods during rush hymenoptera venom immunotherapy.
    Gorska L, Chelminska M, Kuziemski K, Skrzypski M, Niedoszytko M, Damps-Konstanska I, Szymanowska A, Siemińska A, Wajda B, Drozdowska A, Jutel M, Jassem E.
    Int Arch Allergy Immunol; 2008 Apr; 147(3):241-5. PubMed ID: 18594155
    [Abstract] [Full Text] [Related]

  • 3. [Accelerated desensitization for hymenoptera venom allergy in 30 hours: efficacy and safety in 150 cases].
    van der Brempt X, Ledent C, Mairesse M.
    Rev Med Brux; 1997 Jun; 18(3):120-4. PubMed ID: 9273600
    [Abstract] [Full Text] [Related]

  • 4. Rush hymenoptera venom immunotherapy is efficacious and safe.
    Pasaoglu G, Sin BA, Misirligil Z.
    J Investig Allergol Clin Immunol; 2006 Jun; 16(4):232-8. PubMed ID: 16889280
    [Abstract] [Full Text] [Related]

  • 5. Immunoblot studies in allergic patients to hymenoptera venom before and during immunotherapy.
    Pereira Santos MC, Pedro E, Spínola Santos A, Branco Ferreira M, Palma Carlos ML, Palma Carlos AG.
    Eur Ann Allergy Clin Immunol; 2005 Sep; 37(7):273-8. PubMed ID: 16285233
    [Abstract] [Full Text] [Related]

  • 6. Maintenance venom immunotherapy administered at 3-month intervals is both safe and efficacious.
    Goldberg A, Confino-Cohen R.
    J Allergy Clin Immunol; 2001 May; 107(5):902-6. PubMed ID: 11344360
    [Abstract] [Full Text] [Related]

  • 7. [Immunotherapy against hymenoptera venom: report of ten patients].
    Guzmán M MA, Salinas L J, Toche P P, Marinovic M MA, Gallardo O AM.
    Rev Med Chil; 2007 Dec; 135(12):1566-71. PubMed ID: 18357358
    [Abstract] [Full Text] [Related]

  • 8. Three days rush venom immunotherapy in bee allergy: safe, inexpensive and instantaneously effective.
    Goldberg A, Yogev A, Confino-Cohen R.
    Int Arch Allergy Immunol; 2011 Dec; 156(1):90-8. PubMed ID: 21447964
    [Abstract] [Full Text] [Related]

  • 9. Diagnosis and treatment of allergy to hymenoptera venoms.
    Hamilton RG.
    Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):323-9. PubMed ID: 20543672
    [Abstract] [Full Text] [Related]

  • 10. Hymenoptera venom allergy.
    Przybilla B, Ruëff F.
    J Dtsch Dermatol Ges; 2010 Feb; 8(2):114-27; quiz 128-30. PubMed ID: 19751222
    [Abstract] [Full Text] [Related]

  • 11. Safety of specific immunotherapy using a four-hour ultra-rush induction scheme in bee and wasp allergy.
    Roll A, Hofbauer G, Ballmer-Weber BK, Schmid-Grendelmeier P.
    J Investig Allergol Clin Immunol; 2006 Feb; 16(2):79-85. PubMed ID: 16689180
    [Abstract] [Full Text] [Related]

  • 12. Case report of venom immunotherapy for a patient with large local reactions.
    Hamilton RG, Golden DB, Kagey-Sobotka A, Lichtenstein LM.
    Ann Allergy Asthma Immunol; 2001 Aug; 87(2):134-7. PubMed ID: 11527245
    [Abstract] [Full Text] [Related]

  • 13. Rapid venom immunotherapy is safe for routine use in the treatment of patients with Hymenoptera anaphylaxis.
    Bernstein JA, Kagen SL, Bernstein DI, Bernstein IL.
    Ann Allergy; 1994 Nov; 73(5):423-8. PubMed ID: 7978535
    [Abstract] [Full Text] [Related]

  • 14. [A modified ultra-rush-protocol of allergen immunotherapy in children and adolescents with insect venom allergy].
    Steiss JO, Hüls G, Gortner L, Lindemann H.
    Klin Padiatr; 2004 Nov; 216(2):79-82. PubMed ID: 15106079
    [Abstract] [Full Text] [Related]

  • 15. Ultrarush venom desensitization after systemic reactions during conventional venom immunotherapy.
    Oren E, Chegini S, Hamilos DL.
    Ann Allergy Asthma Immunol; 2006 Nov; 97(5):606-10. PubMed ID: 17165267
    [Abstract] [Full Text] [Related]

  • 16. Humoral immunological response in patients with venom allergy during specific immunotherapy.
    Szymański W, Chyrek-Borowska S.
    Rocz Akad Med Bialymst; 1995 Nov; 40(2):376-82. PubMed ID: 8834621
    [Abstract] [Full Text] [Related]

  • 17. A simple 3-day "rush" venom immunotherapy protocol: documentation of safety.
    Kalogeromitros D, Makris M, Koti I, Chliva C, Mellios A, Avgerinou G, Theoharides TC.
    Allergol Immunopathol (Madr); 2010 Nov; 38(2):69-73. PubMed ID: 19853357
    [Abstract] [Full Text] [Related]

  • 18. Venom immunotherapy: tolerance to a 3-day protocol of rush-immunotherapy.
    Díez Gómez ML, Quirce Gancedo S, Juliá de Páramo B.
    Allergol Immunopathol (Madr); 1995 Nov; 23(6):277-84. PubMed ID: 8579006
    [Abstract] [Full Text] [Related]

  • 19. A modified ultrarush insect venom immunotherapy protocol for children.
    Steiss JO, Jödicke B, Lindemann H.
    Allergy Asthma Proc; 2006 Nov; 27(2):148-50. PubMed ID: 16724635
    [Abstract] [Full Text] [Related]

  • 20. Expansion of circulating Foxp3+)D25bright CD4+ T cells during specific venom immunotherapy.
    Pereira-Santos MC, Baptista AP, Melo A, Alves RR, Soares RS, Pedro E, Pereira-Barbosa M, Victorino RM, Sousa AE.
    Clin Exp Allergy; 2008 Feb; 38(2):291-7. PubMed ID: 18070166
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.